Invitro International IVRO:OTCPK

*Data is delayed | Exchange | USD
Last | 05/20/24 EDT
0.075UNCH (UNCH)
52 week range
0.03 - 0.10
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.075
  • 52 Week High0.10
  • 52 Week High Date05/22/23
  • 52 Week Low0.03
  • 52 Week Low Date03/19/24

Key Stats

  • Market Cap1.707M
  • Shares Out22.76M
  • 10 Day Average Volume9,276
  • Dividend-
  • Dividend Yield-
  • Beta-0.82
  • YTD % Change7.14

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.075
  • 52 Week High0.10
  • 52 Week High Date05/22/23
  • 52 Week Low0.03
  • 52 Week Low Date03/19/24
  • Market Cap1.707M
  • Shares Out22.76M
  • 10 Day Average Volume9,276
  • Dividend-
  • Dividend Yield-
  • Beta-0.82
  • YTD % Change7.14

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-13,180.00
  • ROE (TTM)1.09%
  • Revenue (TTM)716,889.977
  • Gross Margin (TTM)-
  • Net Margin (TTM)0.87%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Invitro International

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
InVitro International, Inc. is a customer and technology-driven provider of non-animal testing methods. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. The Company produces and sells in vitro assay kits to detect, rank and predict the potential level of irritancy, toxicity or corrosivity of substances on human eye (ocular) and/or skin tissue (dermal). It sells its...
Irwin Gruverman
Chairman of the Board
W. Richard Ulmer
President, Chief Executive Officer, Director
Address
330 E Orangethorpe Ave Ste D
Placentia, CA
92870
United States